Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Animals | 117 | 2024 | 759 | 5.790 |
Why?
|
Bone Regeneration | 24 | 2023 | 33 | 5.660 |
Why?
|
Bone and Bones | 28 | 2024 | 47 | 4.660 |
Why?
|
Prostheses and Implants | 25 | 2021 | 38 | 4.520 |
Why?
|
Bone Density | 34 | 2022 | 47 | 4.160 |
Why?
|
Femur | 47 | 2021 | 65 | 4.160 |
Why?
|
Osteogenesis | 23 | 2023 | 35 | 3.810 |
Why?
|
Male | 92 | 2023 | 1142 | 3.570 |
Why?
|
Bone Remodeling | 18 | 2021 | 28 | 3.540 |
Why?
|
X-Ray Microtomography | 19 | 2023 | 37 | 2.950 |
Why?
|
Osteolysis | 7 | 2020 | 14 | 2.490 |
Why?
|
Rats | 43 | 2021 | 160 | 2.490 |
Why?
|
Female | 49 | 2024 | 1058 | 2.420 |
Why?
|
Bone Matrix | 6 | 2017 | 9 | 2.370 |
Why?
|
Disease Models, Animal | 16 | 2024 | 97 | 2.250 |
Why?
|
Osseointegration | 16 | 2021 | 23 | 2.160 |
Why?
|
Wnt Signaling Pathway | 3 | 2021 | 6 | 2.070 |
Why?
|
Humans | 74 | 2024 | 2112 | 2.060 |
Why?
|
Osteoporosis | 7 | 2021 | 16 | 2.030 |
Why?
|
Rats, Sprague-Dawley | 32 | 2021 | 95 | 2.000 |
Why?
|
Biomarkers | 8 | 2021 | 57 | 1.990 |
Why?
|
Transforming Growth Factor beta | 13 | 2014 | 20 | 1.960 |
Why?
|
Mice | 17 | 2023 | 219 | 1.920 |
Why?
|
Implants, Experimental | 6 | 2021 | 11 | 1.900 |
Why?
|
Hip Prosthesis | 29 | 2021 | 32 | 1.840 |
Why?
|
Bone Development | 11 | 2023 | 15 | 1.800 |
Why?
|
Cartilage, Articular | 13 | 2017 | 31 | 1.760 |
Why?
|
Titanium | 25 | 2021 | 31 | 1.570 |
Why?
|
Arthroplasty, Replacement, Hip | 7 | 2021 | 11 | 1.340 |
Why?
|
Osteoarthritis | 12 | 2021 | 42 | 1.300 |
Why?
|
Prosthesis Failure | 11 | 2021 | 18 | 1.290 |
Why?
|
Bone Morphogenetic Proteins | 5 | 2015 | 8 | 1.240 |
Why?
|
Calcium, Dietary | 2 | 2018 | 5 | 1.170 |
Why?
|
Tibia | 16 | 2014 | 23 | 1.070 |
Why?
|
Aging | 5 | 2018 | 78 | 1.050 |
Why?
|
Antibodies | 3 | 2015 | 11 | 0.990 |
Why?
|
Endothelial Cells | 2 | 2023 | 6 | 0.980 |
Why?
|
Glycoproteins | 2 | 2015 | 13 | 0.960 |
Why?
|
Calcification, Physiologic | 6 | 2019 | 10 | 0.960 |
Why?
|
Models, Animal | 15 | 2015 | 24 | 0.960 |
Why?
|
Osteocalcin | 4 | 2021 | 10 | 0.940 |
Why?
|
Premature Birth | 1 | 2024 | 1 | 0.930 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2024 | 8 | 0.920 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 28 | 0.920 |
Why?
|
Bone Marrow | 7 | 2023 | 22 | 0.910 |
Why?
|
Aged | 26 | 2021 | 478 | 0.910 |
Why?
|
Cartilage | 4 | 2022 | 13 | 0.880 |
Why?
|
Middle Aged | 33 | 2021 | 553 | 0.870 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2018 | 12 | 0.860 |
Why?
|
Reoperation | 7 | 2021 | 15 | 0.850 |
Why?
|
Bone Resorption | 11 | 2015 | 15 | 0.840 |
Why?
|
Biomechanical Phenomena | 19 | 2020 | 53 | 0.830 |
Why?
|
Circadian Clocks | 1 | 2022 | 4 | 0.830 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 19 | 0.810 |
Why?
|
Inflammation | 2 | 2020 | 17 | 0.790 |
Why?
|
Fractures, Bone | 3 | 2020 | 12 | 0.780 |
Why?
|
Racism | 1 | 2022 | 4 | 0.780 |
Why?
|
Collagen Type I | 2 | 2021 | 4 | 0.770 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 1 | 0.770 |
Why?
|
Body Weight | 4 | 2019 | 16 | 0.760 |
Why?
|
Lactation | 2 | 2018 | 4 | 0.760 |
Why?
|
Dogs | 36 | 2007 | 57 | 0.760 |
Why?
|
Bone Marrow Cells | 7 | 2015 | 18 | 0.740 |
Why?
|
Biocompatible Materials | 8 | 2007 | 11 | 0.720 |
Why?
|
Prosthesis-Related Infections | 2 | 2020 | 3 | 0.710 |
Why?
|
Fracture Healing | 4 | 2014 | 9 | 0.710 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 3 | 0.710 |
Why?
|
Models, Genetic | 1 | 2020 | 3 | 0.710 |
Why?
|
Humerus | 7 | 2014 | 10 | 0.680 |
Why?
|
Stromal Cells | 5 | 2015 | 11 | 0.670 |
Why?
|
Contrast Media | 2 | 2017 | 9 | 0.660 |
Why?
|
Microscopy, Electron, Scanning | 15 | 2017 | 17 | 0.660 |
Why?
|
Minerals | 3 | 2018 | 4 | 0.640 |
Why?
|
Hip Joint | 10 | 2004 | 16 | 0.630 |
Why?
|
Tomography, X-Ray Computed | 13 | 2012 | 74 | 0.630 |
Why?
|
Materials Testing | 8 | 2012 | 16 | 0.630 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 3 | 0.620 |
Why?
|
Weaning | 1 | 2018 | 2 | 0.620 |
Why?
|
Parathyroid Hormone | 2 | 2015 | 6 | 0.620 |
Why?
|
Kidney | 1 | 2018 | 10 | 0.610 |
Why?
|
Adipose Tissue | 1 | 2018 | 6 | 0.610 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 7 | 0.610 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 54 | 0.590 |
Why?
|
Alzheimer Disease | 1 | 2018 | 81 | 0.590 |
Why?
|
Bone Morphogenetic Protein 2 | 7 | 2015 | 10 | 0.590 |
Why?
|
Mice, Inbred C57BL | 5 | 2017 | 57 | 0.590 |
Why?
|
Polyethylene | 2 | 2019 | 4 | 0.580 |
Why?
|
Calcium Phosphates | 5 | 2005 | 7 | 0.580 |
Why?
|
Aged, 80 and over | 13 | 2021 | 239 | 0.560 |
Why?
|
Cortical Bone | 1 | 2017 | 2 | 0.560 |
Why?
|
Osteoarthritis, Knee | 5 | 2010 | 21 | 0.550 |
Why?
|
Coated Materials, Biocompatible | 3 | 2007 | 6 | 0.550 |
Why?
|
Genetic Markers | 2 | 2015 | 6 | 0.530 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 1 | 0.530 |
Why?
|
Radiography | 17 | 2018 | 35 | 0.520 |
Why?
|
Mutation | 1 | 2016 | 64 | 0.510 |
Why?
|
Gene Expression Profiling | 5 | 2010 | 13 | 0.500 |
Why?
|
Adult | 26 | 2010 | 614 | 0.490 |
Why?
|
Extracellular Matrix Proteins | 3 | 2011 | 6 | 0.490 |
Why?
|
Acetabulum | 7 | 2005 | 11 | 0.480 |
Why?
|
Gait | 9 | 2014 | 16 | 0.470 |
Why?
|
Gene Expression | 5 | 2013 | 27 | 0.460 |
Why?
|
Phenotype | 3 | 2022 | 56 | 0.450 |
Why?
|
Knee Prosthesis | 7 | 2014 | 8 | 0.450 |
Why?
|
Cell Movement | 3 | 2012 | 11 | 0.450 |
Why?
|
Knee Joint | 7 | 2014 | 15 | 0.440 |
Why?
|
Metals | 3 | 2011 | 5 | 0.430 |
Why?
|
Heterocyclic Compounds | 2 | 2012 | 2 | 0.430 |
Why?
|
Time Factors | 16 | 2021 | 150 | 0.430 |
Why?
|
Prosthesis Implantation | 3 | 2012 | 5 | 0.430 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2012 | 1 | 0.410 |
Why?
|
Adult Stem Cells | 1 | 2012 | 1 | 0.410 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 10 | 0.410 |
Why?
|
Running | 1 | 2012 | 1 | 0.400 |
Why?
|
Prosthesis Design | 18 | 2005 | 21 | 0.390 |
Why?
|
Mice, Knockout | 4 | 2022 | 43 | 0.390 |
Why?
|
Osteoblasts | 5 | 2015 | 12 | 0.380 |
Why?
|
Mechanical Phenomena | 1 | 2011 | 4 | 0.380 |
Why?
|
Electron Microscope Tomography | 1 | 2011 | 2 | 0.380 |
Why?
|
Ultrasonic Therapy | 4 | 2014 | 5 | 0.380 |
Why?
|
Polymers | 3 | 2007 | 5 | 0.370 |
Why?
|
Weight-Bearing | 7 | 2010 | 13 | 0.350 |
Why?
|
Porosity | 8 | 2018 | 14 | 0.350 |
Why?
|
Stress, Mechanical | 16 | 2007 | 26 | 0.350 |
Why?
|
Recombinant Proteins | 11 | 2014 | 33 | 0.350 |
Why?
|
Cell Differentiation | 4 | 2020 | 33 | 0.340 |
Why?
|
Surface Properties | 8 | 2019 | 17 | 0.340 |
Why?
|
Adaptation, Physiological | 5 | 2001 | 17 | 0.330 |
Why?
|
Durapatite | 3 | 2005 | 4 | 0.320 |
Why?
|
Bone Screws | 5 | 2021 | 10 | 0.310 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2014 | 61 | 0.310 |
Why?
|
Diphosphonates | 2 | 2014 | 5 | 0.310 |
Why?
|
Mice, Transgenic | 4 | 2023 | 27 | 0.310 |
Why?
|
Ultrasonics | 2 | 2005 | 2 | 0.310 |
Why?
|
Tissue Engineering | 2 | 2007 | 5 | 0.310 |
Why?
|
Biomimetic Materials | 2 | 2006 | 3 | 0.300 |
Why?
|
Regeneration | 3 | 2015 | 6 | 0.300 |
Why?
|
Models, Biological | 8 | 2014 | 101 | 0.300 |
Why?
|
Osteocytes | 3 | 2014 | 5 | 0.290 |
Why?
|
Range of Motion, Articular | 2 | 2006 | 16 | 0.290 |
Why?
|
Alkaline Phosphatase | 3 | 2024 | 8 | 0.290 |
Why?
|
Bone Transplantation | 5 | 2004 | 6 | 0.280 |
Why?
|
Infant, Newborn | 3 | 2024 | 54 | 0.280 |
Why?
|
Bone Cements | 9 | 1996 | 10 | 0.280 |
Why?
|
Polyethyleneimine | 3 | 2015 | 6 | 0.270 |
Why?
|
Bone Nails | 4 | 2006 | 4 | 0.270 |
Why?
|
Ovariectomy | 3 | 2021 | 6 | 0.270 |
Why?
|
Mandible | 4 | 2007 | 4 | 0.260 |
Why?
|
Osteogenesis, Distraction | 4 | 2007 | 4 | 0.260 |
Why?
|
Calcium | 2 | 2018 | 191 | 0.260 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 2 | 0.260 |
Why?
|
Tissue Scaffolds | 3 | 2015 | 7 | 0.260 |
Why?
|
Signal Transduction | 4 | 2020 | 71 | 0.250 |
Why?
|
Risk Assessment | 2 | 2018 | 38 | 0.250 |
Why?
|
Sodium Chloride | 1 | 2005 | 7 | 0.250 |
Why?
|
Absorptiometry, Photon | 8 | 2006 | 11 | 0.250 |
Why?
|
Swine | 2 | 2024 | 8 | 0.240 |
Why?
|
Ioxaglic Acid | 2 | 2017 | 3 | 0.240 |
Why?
|
Collagen | 5 | 2016 | 21 | 0.240 |
Why?
|
Anabolic Agents | 1 | 2004 | 2 | 0.240 |
Why?
|
Graft Survival | 1 | 2004 | 11 | 0.240 |
Why?
|
Skull | 2 | 2015 | 7 | 0.240 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 6 | 0.230 |
Why?
|
Lumbar Vertebrae | 4 | 2014 | 27 | 0.230 |
Why?
|
Animals, Newborn | 1 | 2024 | 9 | 0.230 |
Why?
|
Infant, Premature | 1 | 2024 | 11 | 0.230 |
Why?
|
Cells, Cultured | 8 | 2011 | 90 | 0.230 |
Why?
|
Regression Analysis | 4 | 2016 | 17 | 0.230 |
Why?
|
Bone Diseases, Metabolic | 2 | 2021 | 6 | 0.220 |
Why?
|
Alloys | 7 | 2004 | 8 | 0.210 |
Why?
|
Hip | 4 | 2000 | 5 | 0.210 |
Why?
|
Physicians | 1 | 2023 | 15 | 0.210 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 3 | 0.210 |
Why?
|
ARNTL Transcription Factors | 1 | 2022 | 1 | 0.210 |
Why?
|
Epithelial Cells | 1 | 2022 | 2 | 0.210 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 4 | 2009 | 6 | 0.210 |
Why?
|
Random Allocation | 2 | 2012 | 12 | 0.210 |
Why?
|
Joint Prosthesis | 2 | 2020 | 4 | 0.210 |
Why?
|
Anatomy | 1 | 2023 | 24 | 0.200 |
Why?
|
Age Factors | 2 | 2021 | 54 | 0.200 |
Why?
|
Receptors, CXCR4 | 2 | 2012 | 4 | 0.200 |
Why?
|
Circadian Rhythm | 1 | 2022 | 42 | 0.200 |
Why?
|
Cartilage Diseases | 1 | 2002 | 1 | 0.200 |
Why?
|
Risk Factors | 2 | 2021 | 157 | 0.200 |
Why?
|
Talus | 1 | 2002 | 1 | 0.200 |
Why?
|
Imidazoles | 1 | 2002 | 12 | 0.200 |
Why?
|
Wound Healing | 3 | 2015 | 6 | 0.190 |
Why?
|
Photogrammetry | 1 | 2001 | 1 | 0.190 |
Why?
|
Sweden | 1 | 2021 | 2 | 0.190 |
Why?
|
Severity of Illness Index | 2 | 2018 | 63 | 0.190 |
Why?
|
Registries | 1 | 2021 | 12 | 0.190 |
Why?
|
Spinal Fusion | 3 | 1995 | 13 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2015 | 10 | 0.190 |
Why?
|
Immunoassay | 1 | 2021 | 3 | 0.190 |
Why?
|
Palatal Expansion Technique | 1 | 2021 | 1 | 0.180 |
Why?
|
Orthodontic Anchorage Procedures | 1 | 2021 | 1 | 0.180 |
Why?
|
Cancellous Bone | 1 | 2021 | 2 | 0.180 |
Why?
|
United States | 1 | 2022 | 161 | 0.180 |
Why?
|
Transforming Growth Factor beta2 | 3 | 2005 | 4 | 0.180 |
Why?
|
Pilot Projects | 5 | 2015 | 39 | 0.180 |
Why?
|
Tissue and Organ Harvesting | 1 | 2001 | 1 | 0.180 |
Why?
|
Computer Simulation | 4 | 2000 | 30 | 0.180 |
Why?
|
Metatarsus | 1 | 2000 | 1 | 0.180 |
Why?
|
Plasmids | 3 | 2015 | 10 | 0.180 |
Why?
|
Fracture Fixation | 2 | 2014 | 4 | 0.180 |
Why?
|
Bone-Implant Interface | 1 | 2020 | 3 | 0.180 |
Why?
|
Prosthesis Retention | 1 | 2020 | 3 | 0.180 |
Why?
|
Vitallium | 2 | 2011 | 2 | 0.170 |
Why?
|
Movement | 5 | 2006 | 11 | 0.170 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 25 | 0.170 |
Why?
|
Osteoarthritis, Hip | 2 | 2001 | 2 | 0.170 |
Why?
|
NF-kappa B | 1 | 2020 | 5 | 0.170 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 6 | 0.170 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 7 | 0.170 |
Why?
|
Cobalt | 2 | 2014 | 4 | 0.170 |
Why?
|
Motor Activity | 1 | 2019 | 21 | 0.170 |
Why?
|
Hindlimb | 3 | 2012 | 4 | 0.160 |
Why?
|
Femur Neck | 1 | 1999 | 3 | 0.160 |
Why?
|
Treatment Outcome | 5 | 2012 | 142 | 0.160 |
Why?
|
Joints | 3 | 2005 | 8 | 0.160 |
Why?
|
Independent Living | 1 | 2018 | 12 | 0.160 |
Why?
|
Memory, Short-Term | 1 | 2018 | 14 | 0.160 |
Why?
|
Phosphates | 1 | 2018 | 6 | 0.160 |
Why?
|
Prognosis | 1 | 2018 | 30 | 0.160 |
Why?
|
Comorbidity | 1 | 2018 | 31 | 0.160 |
Why?
|
Academic Medical Centers | 1 | 2018 | 13 | 0.160 |
Why?
|
Prevalence | 1 | 2018 | 29 | 0.150 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 38 | 0.150 |
Why?
|
Double-Blind Method | 1 | 2018 | 37 | 0.150 |
Why?
|
Pregnancy | 1 | 2018 | 38 | 0.150 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 14 | 0.150 |
Why?
|
X-Rays | 2 | 2016 | 3 | 0.150 |
Why?
|
Synchrotrons | 2 | 2009 | 2 | 0.150 |
Why?
|
Cell Proliferation | 3 | 2013 | 20 | 0.150 |
Why?
|
Microscopy, Fluorescence | 2 | 2014 | 15 | 0.140 |
Why?
|
Trypsin | 1 | 2017 | 3 | 0.140 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 4 | 0.140 |
Why?
|
Rabbits | 6 | 2015 | 52 | 0.140 |
Why?
|
Gene Transfer Techniques | 2 | 2015 | 10 | 0.140 |
Why?
|
Tensile Strength | 2 | 2012 | 2 | 0.140 |
Why?
|
Proteoglycans | 4 | 2008 | 11 | 0.130 |
Why?
|
Point Mutation | 1 | 2016 | 9 | 0.130 |
Why?
|
Genotype | 1 | 2016 | 37 | 0.130 |
Why?
|
Femoral Fractures | 2 | 2006 | 3 | 0.130 |
Why?
|
Mandibular Condyle | 2 | 2006 | 3 | 0.130 |
Why?
|
Temporal Bone | 2 | 2006 | 4 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2006 | 21 | 0.130 |
Why?
|
Spinal Diseases | 1 | 1995 | 2 | 0.130 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 7 | 0.130 |
Why?
|
Benzylamines | 2 | 2012 | 6 | 0.130 |
Why?
|
RNA | 1 | 2015 | 3 | 0.130 |
Why?
|
Wnt Proteins | 2 | 2012 | 3 | 0.130 |
Why?
|
Arthroplasty, Subchondral | 1 | 2015 | 2 | 0.120 |
Why?
|
Shoulder | 1 | 2015 | 3 | 0.120 |
Why?
|
Periosteum | 2 | 2012 | 3 | 0.120 |
Why?
|
Chondrogenesis | 1 | 2015 | 10 | 0.120 |
Why?
|
DNA Primers | 2 | 2005 | 9 | 0.120 |
Why?
|
RNA, Messenger | 2 | 2005 | 39 | 0.120 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 3 | 0.120 |
Why?
|
Mice, Inbred C3H | 1 | 2015 | 4 | 0.120 |
Why?
|
Down-Regulation | 2 | 2005 | 19 | 0.120 |
Why?
|
Species Specificity | 1 | 2015 | 8 | 0.120 |
Why?
|
Growth Substances | 2 | 2005 | 2 | 0.120 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2015 | 6 | 0.120 |
Why?
|
Reproducibility of Results | 2 | 2014 | 70 | 0.120 |
Why?
|
Nickel | 1 | 2014 | 3 | 0.120 |
Why?
|
Chitosan | 1 | 2014 | 2 | 0.120 |
Why?
|
Copper | 1 | 2014 | 6 | 0.120 |
Why?
|
Microvessels | 1 | 2014 | 3 | 0.120 |
Why?
|
Walking | 5 | 2014 | 7 | 0.120 |
Why?
|
Corpus Striatum | 1 | 2014 | 10 | 0.120 |
Why?
|
Receptors, Dopamine D2 | 1 | 2014 | 5 | 0.120 |
Why?
|
Methamphetamine | 1 | 2014 | 5 | 0.120 |
Why?
|
Cementation | 6 | 1997 | 6 | 0.120 |
Why?
|
Diaphyses | 1 | 2014 | 3 | 0.120 |
Why?
|
Macaca fascicularis | 1 | 2014 | 3 | 0.120 |
Why?
|
Organ Specificity | 1 | 2014 | 4 | 0.120 |
Why?
|
Osteoporotic Fractures | 1 | 2014 | 3 | 0.110 |
Why?
|
Calcitonin | 1 | 2014 | 4 | 0.110 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 4 | 0.110 |
Why?
|
Reference Values | 2 | 2012 | 21 | 0.110 |
Why?
|
Etidronic Acid | 2 | 2004 | 2 | 0.110 |
Why?
|
Alendronate | 2 | 2004 | 3 | 0.110 |
Why?
|
Polyethylenes | 4 | 1998 | 4 | 0.110 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2013 | 2 | 0.110 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2014 | 14 | 0.110 |
Why?
|
Ossification, Heterotopic | 4 | 2009 | 4 | 0.110 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 8 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 5 | 0.100 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 2 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2012 | 15 | 0.100 |
Why?
|
Adolescent | 4 | 2002 | 211 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 1 | 0.100 |
Why?
|
Matrix Metalloproteinases | 2 | 2010 | 4 | 0.090 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 2 | 0.090 |
Why?
|
Calcineurin | 1 | 2011 | 3 | 0.090 |
Why?
|
Metatarsal Bones | 2 | 2003 | 2 | 0.090 |
Why?
|
Gap Junctions | 1 | 2011 | 1 | 0.090 |
Why?
|
Cell Communication | 1 | 2011 | 5 | 0.090 |
Why?
|
Spinal Cord | 1 | 2010 | 7 | 0.090 |
Why?
|
DNA | 3 | 2015 | 24 | 0.090 |
Why?
|
Equipment Design | 4 | 2010 | 12 | 0.090 |
Why?
|
Ganglia, Spinal | 1 | 2010 | 11 | 0.090 |
Why?
|
Rats, Inbred F344 | 3 | 2015 | 7 | 0.090 |
Why?
|
Nociceptors | 1 | 2010 | 7 | 0.090 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2007 | 2 | 0.090 |
Why?
|
Quadriceps Muscle | 1 | 2010 | 1 | 0.090 |
Why?
|
Knee | 1 | 2010 | 3 | 0.090 |
Why?
|
Arthralgia | 1 | 2010 | 12 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2010 | 7 | 0.090 |
Why?
|
Fracture Fixation, Internal | 1 | 1990 | 2 | 0.090 |
Why?
|
Elasticity | 5 | 2001 | 11 | 0.090 |
Why?
|
Scattering, Radiation | 2 | 2009 | 8 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 7 | 0.080 |
Why?
|
Pan troglodytes | 1 | 1989 | 6 | 0.080 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2008 | 5 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 13 | 0.080 |
Why?
|
Up-Regulation | 2 | 2007 | 12 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 4 | 2015 | 21 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2005 | 77 | 0.080 |
Why?
|
Equipment Failure Analysis | 2 | 2006 | 6 | 0.080 |
Why?
|
Hemarthrosis | 1 | 2008 | 3 | 0.080 |
Why?
|
Hemophilia A | 1 | 2008 | 10 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2007 | 2 | 0.070 |
Why?
|
Craniosynostoses | 1 | 2007 | 2 | 0.070 |
Why?
|
Cell Line | 3 | 2014 | 50 | 0.070 |
Why?
|
Cell Lineage | 1 | 2007 | 8 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 7 | 0.070 |
Why?
|
Chromium Alloys | 2 | 2005 | 4 | 0.070 |
Why?
|
Acrylic Resins | 1 | 2007 | 1 | 0.070 |
Why?
|
Temporomandibular Joint | 1 | 2007 | 3 | 0.070 |
Why?
|
Guided Tissue Regeneration | 1 | 2006 | 1 | 0.070 |
Why?
|
Hydroxyapatites | 2 | 2005 | 4 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2006 | 5 | 0.070 |
Why?
|
Prospective Studies | 3 | 2003 | 126 | 0.070 |
Why?
|
X-Ray Diffraction | 1 | 2006 | 1 | 0.070 |
Why?
|
Posture | 1 | 2006 | 5 | 0.070 |
Why?
|
Models, Anatomic | 1 | 2006 | 8 | 0.070 |
Why?
|
Radiographic Image Enhancement | 2 | 2004 | 2 | 0.070 |
Why?
|
Body Mass Index | 1 | 2006 | 40 | 0.060 |
Why?
|
Locomotion | 1 | 2005 | 2 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2005 | 2 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2005 | 4 | 0.060 |
Why?
|
In Vitro Techniques | 3 | 2006 | 67 | 0.060 |
Why?
|
Cattle | 2 | 2021 | 14 | 0.060 |
Why?
|
Chymopapain | 2 | 2003 | 2 | 0.060 |
Why?
|
Shear Strength | 1 | 2005 | 3 | 0.060 |
Why?
|
Delayed-Action Preparations | 1 | 2005 | 4 | 0.060 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2005 | 1 | 0.060 |
Why?
|
Orthopedics | 1 | 2005 | 1 | 0.060 |
Why?
|
Algorithms | 2 | 2014 | 41 | 0.060 |
Why?
|
Base Sequence | 1 | 2005 | 18 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 10 | 0.060 |
Why?
|
Evaluation Studies as Topic | 2 | 1997 | 4 | 0.060 |
Why?
|
Bone Marrow Purging | 1 | 2004 | 1 | 0.060 |
Why?
|
Cell Survival | 2 | 2015 | 13 | 0.060 |
Why?
|
Genetic Therapy | 2 | 2015 | 18 | 0.060 |
Why?
|
Temperature | 1 | 2004 | 11 | 0.060 |
Why?
|
Jogging | 1 | 2004 | 1 | 0.060 |
Why?
|
Orthopedic Fixation Devices | 2 | 2014 | 4 | 0.060 |
Why?
|
Growth Plate | 1 | 2003 | 2 | 0.050 |
Why?
|
Professionalism | 1 | 2023 | 1 | 0.050 |
Why?
|
Personal Autonomy | 1 | 2023 | 1 | 0.050 |
Why?
|
Ankle Joint | 1 | 2003 | 1 | 0.050 |
Why?
|
Anthropometry | 1 | 2003 | 7 | 0.050 |
Why?
|
Protective Agents | 1 | 2003 | 1 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 15 | 0.050 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 2 | 0.050 |
Why?
|
Hyaluronic Acid | 1 | 2003 | 5 | 0.050 |
Why?
|
Amino Acids | 1 | 2002 | 1 | 0.050 |
Why?
|
Transplantation, Autologous | 3 | 2007 | 3 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2002 | 45 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 20 | 0.050 |
Why?
|
Rats, Zucker | 1 | 2021 | 2 | 0.050 |
Why?
|
Child, Preschool | 2 | 1996 | 90 | 0.050 |
Why?
|
Infant | 2 | 1996 | 91 | 0.050 |
Why?
|
Palate | 1 | 2021 | 1 | 0.050 |
Why?
|
Ilium | 1 | 2001 | 1 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2001 | 1 | 0.050 |
Why?
|
Wrist Joint | 1 | 2001 | 1 | 0.050 |
Why?
|
Radiation Dosage | 2 | 2011 | 5 | 0.050 |
Why?
|
Child | 2 | 1996 | 158 | 0.050 |
Why?
|
Radius | 1 | 2001 | 2 | 0.050 |
Why?
|
Elbow Joint | 1 | 2001 | 2 | 0.050 |
Why?
|
Sex Factors | 4 | 2003 | 44 | 0.050 |
Why?
|
Arthroplasty, Replacement | 1 | 2020 | 3 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2000 | 2 | 0.040 |
Why?
|
Analysis of Variance | 4 | 2007 | 24 | 0.040 |
Why?
|
Osteoclasts | 1 | 2020 | 2 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2007 | 10 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 1996 | 5 | 0.040 |
Why?
|
Mechanics | 1 | 1998 | 2 | 0.040 |
Why?
|
Arthrography | 1 | 1998 | 2 | 0.040 |
Why?
|
Microradiography | 2 | 2005 | 2 | 0.040 |
Why?
|
Software | 1 | 1998 | 8 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 9 | 0.040 |
Why?
|
Oligopeptides | 2 | 2007 | 6 | 0.030 |
Why?
|
Sialoglycoproteins | 2 | 2007 | 3 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 2015 | 4 | 0.030 |
Why?
|
Collagen Type III | 1 | 2015 | 1 | 0.030 |
Why?
|
Foreign Bodies | 1 | 1995 | 7 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2014 | 1 | 0.030 |
Why?
|
Molybdenum | 1 | 2014 | 1 | 0.030 |
Why?
|
Chromium | 1 | 2014 | 2 | 0.030 |
Why?
|
Cell Death | 1 | 2014 | 3 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 10 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 2 | 0.030 |
Why?
|
Hypoxia | 1 | 2014 | 3 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 2014 | 3 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2014 | 3 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2014 | 10 | 0.030 |
Why?
|
Self Administration | 1 | 2014 | 6 | 0.030 |
Why?
|
Hardness | 1 | 1994 | 1 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1994 | 2 | 0.030 |
Why?
|
Rotation | 1 | 1994 | 9 | 0.030 |
Why?
|
Thiophenes | 1 | 2014 | 3 | 0.030 |
Why?
|
Physical Examination | 1 | 2014 | 7 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2013 | 11 | 0.030 |
Why?
|
Transfection | 1 | 2013 | 19 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 25 | 0.030 |
Why?
|
Calcineurin Inhibitors | 1 | 2011 | 1 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 17 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 26 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2011 | 10 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2010 | 3 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 2 | 0.020 |
Why?
|
Transducers | 1 | 2010 | 3 | 0.020 |
Why?
|
Blotting, Western | 1 | 2010 | 20 | 0.020 |
Why?
|
Phosphorylation | 1 | 2010 | 25 | 0.020 |
Why?
|
Chondrocytes | 1 | 2010 | 16 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2010 | 8 | 0.020 |
Why?
|
Muscle Strength | 1 | 2010 | 6 | 0.020 |
Why?
|
Histological Techniques | 1 | 1990 | 2 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 1990 | 14 | 0.020 |
Why?
|
Pain Measurement | 1 | 2010 | 27 | 0.020 |
Why?
|
Pain Management | 1 | 2010 | 15 | 0.020 |
Why?
|
Pain | 1 | 2010 | 27 | 0.020 |
Why?
|
Normal Distribution | 1 | 2009 | 1 | 0.020 |
Why?
|
Absorption | 1 | 2009 | 2 | 0.020 |
Why?
|
Silicon | 1 | 2009 | 3 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2009 | 1 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2009 | 8 | 0.020 |
Why?
|
Apoptosis | 1 | 2009 | 32 | 0.020 |
Why?
|
Air | 1 | 1989 | 2 | 0.020 |
Why?
|
Ethanol | 1 | 1989 | 2 | 0.020 |
Why?
|
Water | 1 | 1989 | 6 | 0.020 |
Why?
|
Synovitis | 1 | 2008 | 3 | 0.020 |
Why?
|
Factor VIII | 1 | 2008 | 7 | 0.020 |
Why?
|
Sampling Studies | 1 | 1988 | 3 | 0.020 |
Why?
|
Research Design | 1 | 1988 | 21 | 0.020 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2007 | 1 | 0.020 |
Why?
|
Osteotomy | 1 | 2007 | 4 | 0.020 |
Why?
|
Cadaver | 2 | 1998 | 22 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 68 | 0.020 |
Why?
|
Muscle, Skeletal | 2 | 1998 | 68 | 0.020 |
Why?
|
Acrylates | 1 | 2007 | 1 | 0.020 |
Why?
|
Ethylene Glycol | 1 | 2007 | 1 | 0.020 |
Why?
|
Dactinomycin | 1 | 2007 | 1 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 1 | 0.020 |
Why?
|
Growth Differentiation Factor 5 | 1 | 2007 | 1 | 0.020 |
Why?
|
Cycloheximide | 1 | 2007 | 2 | 0.020 |
Why?
|
Biomimetics | 1 | 2006 | 3 | 0.020 |
Why?
|
Autoanalysis | 1 | 1985 | 1 | 0.020 |
Why?
|
Paleontology | 1 | 1985 | 1 | 0.020 |
Why?
|
Mandibular Nerve | 1 | 2005 | 1 | 0.020 |
Why?
|
Internal Fixators | 1 | 2005 | 3 | 0.020 |
Why?
|
Osteonectin | 1 | 2005 | 1 | 0.020 |
Why?
|
Genes, myc | 1 | 2005 | 1 | 0.020 |
Why?
|
Genes, jun | 1 | 2005 | 1 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2005 | 1 | 0.020 |
Why?
|
Early Growth Response Protein 1 | 1 | 2005 | 1 | 0.020 |
Why?
|
Osteopontin | 1 | 2005 | 1 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2005 | 2 | 0.020 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 2 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 5 | 0.020 |
Why?
|
Transcription Factors | 1 | 2005 | 35 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 23 | 0.020 |
Why?
|
Fetus | 1 | 1984 | 2 | 0.010 |
Why?
|
Mathematics | 1 | 1984 | 18 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2003 | 1 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2003 | 1 | 0.010 |
Why?
|
Decorin | 1 | 2003 | 1 | 0.010 |
Why?
|
Biglycan | 1 | 2003 | 1 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 2 | 0.010 |
Why?
|
Anterior Cruciate Ligament | 1 | 2003 | 3 | 0.010 |
Why?
|
Aggrecans | 1 | 2003 | 3 | 0.010 |
Why?
|
Compressive Strength | 1 | 2003 | 3 | 0.010 |
Why?
|
Keratan Sulfate | 1 | 2003 | 1 | 0.010 |
Why?
|
Viscosity | 1 | 2003 | 1 | 0.010 |
Why?
|
Models, Statistical | 1 | 2003 | 20 | 0.010 |
Why?
|
Injections, Intra-Articular | 1 | 2003 | 6 | 0.010 |
Why?
|
Postoperative Complications | 2 | 1993 | 30 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2000 | 79 | 0.010 |
Why?
|
Forecasting | 1 | 1998 | 10 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1998 | 37 | 0.010 |
Why?
|
Calibration | 1 | 1998 | 2 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 1997 | 1 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1997 | 10 | 0.010 |
Why?
|
Microscopy, Polarization | 1 | 1996 | 1 | 0.010 |
Why?
|
Autopsy | 1 | 1996 | 12 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1996 | 118 | 0.010 |
Why?
|
Foreign-Body Migration | 1 | 1995 | 1 | 0.010 |
Why?
|
Fibrosis | 1 | 1995 | 4 | 0.010 |
Why?
|
Methods | 1 | 1993 | 3 | 0.010 |
Why?
|
Drug Combinations | 1 | 1993 | 3 | 0.010 |
Why?
|
Postoperative Period | 1 | 1993 | 4 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1992 | 13 | 0.010 |
Why?
|
Cryopreservation | 1 | 1992 | 2 | 0.010 |
Why?
|
Metallurgy | 1 | 1986 | 1 | 0.000 |
Why?
|